Sanofi-Aventis (Suisse) SA - VaxigripTetra, Suspension pour injection dans une seringue pré-remplie | | 66427 | | 02 | | VaxigripTetra | | Suspension pour injection dans une seringue pré-remplie | | J07BB02 | | Influenza, gereinigtes Antigen | | 08.08.2018 | | |
| Zusammensetzung | haemagglutininum influenzae A (H1N1) (Virus souche A/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Singapore/INFIMH-16-0019/2016 (H3N2)-like: reassortant virus IVR-186) 15 µg, haemagglutininum influenzae B (Virus souche B/Colorado/06/2017-like: reassortant virus NYMC BX-69A derived from B/Maryland/15/2016 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013-like: reassortant virus Wild type derived from B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. | Packungsbestandteile | | Suspension pour injection dans une seringue pré-remplie | | | | Wirkstoffe | Stärke |
---|
Haemagglutininum Influenzae a (H1N1) (Virus Souche A/michigan/45/2015 (H1N1)-Like: Reassortant Virus nymc X-275) | 15 µg | Haemagglutininum Influenzae a (H3N2) (Virus Souche A/singapore/infimh-16-0019/2016 (H3N2)-Like: Reassortant Virus Ivr-186) | 15 µg | Haemagglutininum Influenzae b (Virus Souche B/colorado/06/2017-Like: Reassortant Virus nymc Bx-69A Derived from B/maryland/15/2016 (Victoria Lineage)) | 15 µg |
| | Hilfsstoffe | Stärke |
---|
Dinatrium Phosphat Dihydrat | | Haemagglutininum Influenzae b (Virus Souche B/phuket/3073/2013-Like: Reassortant Virus wild type Derived from B/phuket/3073/2013 (Yamagata Lineage)) | 15 µg | Kalium Chlorid | | Kalium Dihydrogenophosphat | | Natrium Chlorid | |
|
| Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
---|
Es wurden keine Einträge gefunden. |
|
|